Trends of Molecular Testing for Lung Cancer at the King Faisal Hospital, Kigali: Therapeutic and Survival Implications

Introduction: Lung cancer is the leading cause of cancer mortality worldwide, both in high and low resource settings. Knowledge has been generated elsewhere regarding molecular subtyping and subsequent targeted therapy development, contributing substantially to patient survival. Little is known on t...

Descripció completa

Dades bibliogràfiques

Autors principals:	Achille Van Christ Manirakiza, MD, Fidel Rubagumya, MD, Eulade Rugengamanzi, MD, Alphonsine Mukandekezi, MD, Jessica Beneyo, BMLS, Maurice Musoni, MD, Thierry Zawadi Muvunyi, MD
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2022-04-01
Col·lecció:	JTO Clinical and Research Reports
Matèries:	Lung cancer Molecular and biomarker testing Targeted therapy Rwanda LMICs
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2666364322000285
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!